SYNOVANCE, founded in 2017, operates at the intersection of Biotechnology and Clean Energy. Based in France, the company seeks to redefine the production of high-value chemicals and enzymes through the engineering of secondary genomes.
With the slogan "Engineering a Sustainable Future," SYNOVANCE is committed to advancing the circular economy model. They are currently focused on establishing a biorefinery utilizing second-generation sustainable feedstocks for fermentation, highlighting their innovative approach to sustainability.
Their most recent financial milestone was a Seed Round investment, secured on 01 December 2021, which was led by investor Alain Garnier. This investment underscores the market's confidence in their technological prowess and growth potential.